GAINESVILLE, Fla., May 11, 2010 (GLOBE NEWSWIRE) -- Quick-Med Technologies, Inc. (OTCBB:QMDT) today announced that it has retained The Ruth Group to manage its investor and public relations programs. The Ruth Group is a New York City-based full service investor and public relations agency which provides top-tier counsel, communications strategies and capital markets advisory to healthcare companies.
"As we continue to deliver on the promise of our NIMBUS® technology to add value in multiple medical device applications, we believe The Ruth Group's expertise and strategic counsel will add significant value to our efforts to increase visibility within the financial and medical communities," said Ladd Greeno, Quick-Med's CEO.
"Quick-Med is an innovative life sciences company with breakthrough technologies for the healthcare and consumer markets," said Carol Ruth, President and Founder of The Ruth Group. "We look forward to working with the Quick-Med team to bring greater visibility to the Company and its unique investment opportunity."
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. Quick-Med is developing NIMBUS applications in several other advanced wound dressing formats including adhesives, foams, hydrogels, films, and hydrocolloids. For more information, see: www.quickmedtech.com.
About The Ruth Group
The Ruth Group (TRG) is a New York City-based full service investor and public relations agency providing top-tier counsel, communications strategies and capital markets advisory to healthcare and technology companies. In-depth, sector-specific expertise differentiates TRG from all other agencies through specialized teams dedicated to healthcare services, medical technology, specialty pharmaceuticals, biotechnology, alternative energy, internet media and technology. Each team is run by professionals available 24/7 and skilled in the areas of finance, corporate communications, industry and science. For more information please visit http://www.theruthgroup.com/.
© 2010 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® is a registered trademark of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.